Private Investors' Incubators for University-Sourced Ideas

9:45 AM - 10:40 AM, Tuesday, October 22, 2019 ・ 2nd Floor
Recognizing a persistent “valley of death” in funding for medical research past the government-grant stage, several organizations have recently launched specialized investment vehicles. These vehicles are specifically designed to support translational research for university-sourced ideas to become independent companies capable of moving biological ideas into human drug development and to attract conventional venture investors. Hear from investors, academics, and entrepreneurs pursuing these new approaches that resolve critical bottlenecks as they work to lower initial project risks and accelerate progress through proof-of-concept.
Speakers
photo
Managing Director
Lagunita Biosciences
photo
Chairman and CEO
Xontogeny; Portfolio Manager—Venture, Perceptive Advisors
photo
Chief Operating Officer, Lilly Research Labs
Eli Lilly and Company
photo
Co-Director, SPARK Translational Research Program
Stanford University
photo
Managing Director
BioMotiv
photo
Director of Life Sciences
The Labs by Sterling Bay